NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









J-Pharma

J-Pharma

Public

J-Pharma is now publicly traded

The data on this page reflects J-Pharma's private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Last Round

Series F

Jul 7, 2025

Total Funding Raised

$73.89M

Company Overview

J-Pharma is a biotechnology company that specializes in the research and development of novel drugs targeting SLC transporters, particularly L-type amino acid transporter 1 (LAT1), for the treatment of cancer and autoimmune diseases.

Sector

Biotech

AI Layer

Non-AI

Keywords

biopharmaceuticaloncologyLAT1 inhibitornanvuranlatclinical trialsdrug discoverycancer therapysmall-molecule drugbiotechsolid tumor treatmentbiliary tract cancerL-type amino acid transporter 1LAT1clinical-stage biotechdrug pipeline

J-Pharma Comparables

Compare J-Pharma with similar companies based on industry and business-model similarity.

J-Pharma comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

J-Pharma Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series FJul 7, 2025
GrantApr 1, 2025
Series E ExtensionApr 1, 2025
Series EOct 5, 2023
Series DJul 30, 2020

Key People

Founding team and executive leadership

Yutaka Fujimoto

CFO

Executive Team

J-Pharma Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

J-Pharma Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersJapan
Employee Range22
Year Founded2005
Last FundingJul 7, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.